CHICAGO – In a groundbreaking revelation at the annual Advances in Contrast Ultrasound conference in Chicago, medical professionals are increasingly endorsing contrast enhanced ultrasound (CEUS) as the preferred imaging technique for kidney masses in patients suffering from polycystic kidney disease. Renowned radiologist Dr. Richard Barr emphasized that many doctors are bypassing traditional CT scans in favor of CEUS due to its efficacy and safety profile.
Dr. Barr highlighted that nephrologists and other specialists favor CEUS for its ability to deliver quick, accurate results without the high costs, risk of kidney damage, or radiation exposure associated with contrast-enhanced CT or MR procedures.
“CEUS not only benefits patients but also provides financial advantages for healthcare providers,” Dr. Barr noted. “Many practitioners may not be aware that reimbursement rates for using CEUS are higher in comparison to CT or MR, irrespective of the organ being examined or the ultrasound contrast agent used.”
CEUS, complemented by grayscale ultrasound, plays an essential role in the detection of solid renal masses. ICUS Board Member Christine Merrill shared an illustrative case of a 70-year-old patient diagnosed with adult polycystic kidney disease, where initial CT results indicated a singular suspect mass in the right kidney. Further examination with CEUS revealed five solid masses in both kidneys, showcasing the enhanced detection capabilities of this imaging technique.
Ultrasound contrast agents, which consist of safe echogenic microbubbles administered intravenously during the procedure, are instrumental in identifying tumors and abnormalities across various organ systems, including the kidneys, liver, bowel, and heart.
In light of these findings, the medical community is urged to consider the significant advantages of utilizing CEUS for kidney imaging to improve patient outcomes and streamline care.
For further insights on CEUS and its role in modern medicine, stay tuned for updates from ECNETNews.
